Michael J Malinowski

Personal Genome Medicine

The Legal and Regulatory Transformation of Us Medicine

• Gebundenes Buch

Produktbeschreibung

"The United States' decentralized, largely privatized, and commerce-driven healthcare system is undergoing a shift to personal genome medicine. This change is charged by ongoing progress in biotech and genomic research and development. This book draws from U.S. medicine's past and present to address its emerging personal genome medicine future"--

---

Hinweis: Dieser Artikel kann nur an eine deutsche Lieferadresse ausgeliefert werden.

Produktdetails

• Verlag: Cambridge University Press
• Seitenzahl: 480
• Erscheinungstermin: 31. August 2023
• Englisch
• Abmessung: 229mm x 152mm x 27mm
• Gewicht: 807g
• ISBN-13: 9781009293327
• ISBN-10: 100929332X
• Artikelnr.: 67257270

Autorenporträt

Michael J. Malinowski is the Ernest R. and Iris M. Eldred Endowed Professor of Law and the Lawrence B. Sandoz Jr. Endowed Professor of Law at the Paul M. Hebert Law Center, Louisiana State University. He has published extensively on biotechnology research and development (R&D), health care, and bioethics.

Inhaltsangabe

Prologue: revolution, transition and transformation; 1. Medical profession
sovereignty to protect and promote the science and evidence base of US
medicine; 2. US integration of government, academia and industry: a
catalyst for science-technology revolutions; 3. The proliferation of US
Direct-to-Consumer (DTC) and Direct-to-Physician (DTP) biopharmaceutical
marketing; 4. The evolution of consumer genetic testing services from
Oncormed, Inc. to 23andMe Holding Co.; 5. Vulnerability of the science and
evidence base of US medicine; 6. A warning label for commercial
Direct-to-Consumer (DTC) genetics; 7. Protecting and promoting the
evidentiary-science base of Personal Genome Medicine (PGM); Epilogue: the
personal genome future of US medicine.